WOC2014 TOKYO World Ophthalmology Congress® of the International Council of Ophthalmology 2014年 4月5日（土） 12:15 13:15 Date : Saturday, April 5, 2014 12:15-13:15 Lunch Seminar 40 第9会場（東京国際フォーラムガラス棟6階 G602） Venue : Room No. 9 / G602 / Tokyo International Forum 網膜色素変性の Recent managements of retinitis pigmentosa 最新情報座長三宅養三先生（愛知医科大学理事長） Yozo Miyake, M.D., Ph.D., Chairman of the Board of Directors, Aichi Medical University Epidemiologic researches of RP patients with mid to late stages are necessary to develop appropriate clinical endpoints for coming new treatments. Although visual acuity is the most common clinical endpoint, it takes long time to show the prevention of loss of vision in the clinical trial through new therapies. To develop the new therapies for RP, clinician scientists who are familiar with not only basic and clinical researches but also applied research will play important roles. In this seminar, three clinician scientists will present the managements of recent RP treatments: clinical endpoints for RP study, gene therapy, and iPS cell therapy. 演者 1 Program 1 「網膜色素変性における視機能評価」 “Evaluation of visual function in retinitis pigmentosa” 山本修一先生（千葉大学大学院医学研究院眼科学教授） Shuichi Yamamoto, M.D., Ph.D., Vice Director of Chiba University Hospital Professor and Chairman, Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine 演者 2 Program 2 「網膜色素変性に対する視細胞保護遺伝子治療臨床研究の進捗状況」 “Phase I clinical trial of neuroprotective gene therapy for patients with retinitis pigmentosa” 池田康博先生（九州大学大学院医学研究院眼科学講師） Yasuhiro Ikeda, M.D., Ph.D., Assistant professor, Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University 演者 3 Program 3 「iPS細胞の網膜疾患への応用」 “Application of iPS cells for retinal diseases” 高橋政代先生（理化学研究所発生・再生科学総合研究センター網膜再生医療研究開発プロジェクトプロジェクトリーダー） Masayo Takahashi, M.D., Ph.D., Project Leader, Laboratory for Retinal Regeneration, Center for Developmental Biology, RIKEN, Japan The talks in this seminar will be given in Japanese. 共催：WOC2014 TOKYO／株式会社アールテック・ウエノ